Thomas Edward Hamilton

Insider Reports History

Location
Rye, NY
Signature
/s/ Anthony C. Green, as Attorney-in-Fact for Thomas Edward Hamilton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Edward Hamilton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Larimar Therapeutics, Inc. Director Common Stock 564,798 $4,936,335 $8.74 16 Feb 2024 Direct
ANNALY CAPITAL MANAGEMENT INC Director Common Stock 82,500 $1,552,650 $18.82 14 May 2025 Cure FA Foundation, Inc.
Larimar Therapeutics, Inc. Director Common Stock 159,433 $1,393,444 $8.74 16 Feb 2024 Post Edison, LLC
ANNALY CAPITAL MANAGEMENT INC Director Common Stock 32,500 $611,650 $18.82 14 May 2025 Direct
ANNALY CAPITAL MANAGEMENT INC Director Deferred Stock Units 45,243 14 May 2025 Direct
Larimar Therapeutics, Inc. Director Stock Option (Right to Buy) 19,000 13 May 2025 Direct

Insider Reports Filed by Thomas Edward Hamilton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NLY ANNALY CAPITAL MANAGEMENT INC 14 May 2025 1 $0 4 Director 15 May 2025, 16:16
LRMR Larimar Therapeutics, Inc. 13 May 2025 1 $0 4 Director 14 May 2025, 16:33
NLY ANNALY CAPITAL MANAGEMENT INC 15 May 2024 1 $0 4 Director 17 May 2024, 17:44
LRMR Larimar Therapeutics, Inc. 16 Feb 2024 2 $499,997 4 Director 31 May 2024, 16:56
NLY ANNALY CAPITAL MANAGEMENT INC 17 May 2023 1 $0 4 Director 19 May 2023, 16:53
LRMR Larimar Therapeutics, Inc. 09 May 2023 1 $0 4 Director 11 May 2023, 16:29
LRMR Larimar Therapeutics, Inc. 16 Sep 2022 1 $999,999 4 Director 20 Sep 2022, 06:54
NLY ANNALY CAPITAL MANAGEMENT INC 18 May 2022 1 $0 4 Director 20 May 2022, 17:04
LRMR Larimar Therapeutics, Inc. 10 May 2022 1 $0 4 Director 12 May 2022, 20:27
LRMR Larimar Therapeutics, Inc. 30 Jun 2021 1 $496,212 4 Director 02 Jul 2021, 16:08
NLY ANNALY CAPITAL MANAGEMENT INC 19 May 2021 1 $0 4 Director 21 May 2021, 18:25
LRMR Larimar Therapeutics, Inc. 12 May 2021 1 $0 4 Director 17 May 2021, 16:59